Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Xenetic Biosciences - 13 Year Stock Price History | XBIO

Historical daily share price chart and data for Xenetic Biosciences since 2012 adjusted for splits and dividends. The latest closing stock price for Xenetic Biosciences as of November 14, 2025 is 2.60.
  • The all-time high Xenetic Biosciences stock closing price was 59394.10 on January 03, 2014.
  • The Xenetic Biosciences 52-week high stock price is 13.93, which is 435.8% above the current share price.
  • The Xenetic Biosciences 52-week low stock price is 2.20, which is 15.4% below the current share price.
  • The average Xenetic Biosciences stock price for the last 52 weeks is 3.53.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Xenetic Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.4433 4.0500 10.3600 2.3000 2.6000 -34.84%
2024 3.9550 3.5650 4.7200 3.1500 3.9900 15.65%
2023 4.0675 3.0505 7.2900 2.6600 3.4501 21.01%
2022 7.6940 13.7000 13.7000 2.7000 2.8510 -77.90%
2021 22.3857 21.5000 53.0000 12.7000 12.9000 -36.76%
2020 11.0013 14.0000 31.7000 4.9000 20.4000 41.67%
2019 104.6355 204.0000 298.8000 10.5000 14.4000 -92.68%
2018 300.2539 228.0000 714.0000 181.2000 196.8000 -14.52%
2017 388.2661 647.8680 652.8000 214.8120 230.2200 -55.38%
2016 807.7789 1722.4300 1722.4300 396.0000 516.0000 -74.45%
2015 1345.4272 989.9010 3642.8400 712.7290 2019.4000 104.00%
2014 4737.3415 59394.1000 59394.1000 692.9310 989.9010 25.00%
2013 791.9210 791.9210 791.9210 791.9210 791.9210 33.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.003B
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen(TM), its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen(TM) has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The Company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and expects to earn royalty payments under this agreement.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.303B 32.40
Zoetis (ZTS) United States $53.394B 19.11
Takeda Pharmaceutical (TAK) Japan $45.311B 9.25
Daiichi Sankyo, - (DSNKY) Japan $41.164B 20.50
BeOne Medicines - (ONC) Switzerland $40.396B 214.16
Sandoz Group AG (SDZNY) Switzerland $30.312B 0.00
United Therapeutics (UTHR) United States $19.905B 17.52
Merck (MKKGY) Germany $18.217B 11.23
Shionogi (SGIOY) Japan $14.768B 13.56
Neurocrine Biosciences (NBIX) United States $14.374B 34.49
Summit Therapeutics (SMMT) United States $14.081B 0.00
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.695B 0.00
Ionis Pharmaceuticals (IONS) United States $11.312B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Eisai (ESAIY) $8.353B 0.00
Corcept Therapeutics (CORT) United States $7.968B 86.08
Stevanato Group S.p.A (STVN) Italy $6.862B 38.41
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.130B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.931B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.621B 17.19
Centessa Pharmaceuticals (CNTA) United Kingdom $3.478B 0.00
Hypermarcas (HYPMY) Brazil $3.028B 20.78
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.829B 9.03
Dyne Therapeutics (DYN) United States $2.689B 0.00
Soleno Therapeutics (SLNO) United States $2.543B 0.00
Ocular Therapeutix (OCUL) United States $2.384B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.007B 23.78
Guardian Pharmacy Services (GRDN) United States $1.926B 37.10
Avadel Pharmaceuticals (AVDL) Ireland $1.879B 0.00
Collegium Pharmaceutical (COLL) United States $1.466B 7.26
BioCryst Pharmaceuticals (BCRX) United States $1.453B 86.25
Ardelyx (ARDX) United States $1.417B 0.00
Harrow (HROW) United States $1.403B 86.11
Amylyx Pharmaceuticals (AMLX) United States $1.364B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Enliven Therapeutics (ELVN) United States $1.203B 0.00
Evotec AG (EVO) Germany $1.126B 0.00
Relay Therapeutics (RLAY) United States $1.118B 0.00
Nektar Therapeutics (NKTR) United States $1.097B 0.00
Oruka Therapeutics (ORKA) United States $1.096B 0.00
Xencor (XNCR) United States $0.999B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
Theravance Biopharma (TBPH) United States $0.910B 38.19
Savara (SVRA) United States $0.867B 0.00
ARS Pharmaceuticals (SPRY) United States $0.831B 0.00
Organogenesis (ORGO) United States $0.788B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.724B 6.46
Elite Pharmaceuticals (ELTP) United States $0.719B 0.00
Esperion Therapeutics (ESPR) United States $0.708B 0.00
ProKidney (PROK) United States $0.671B 0.00
KalVista Pharmaceuticals (KALV) United States $0.662B 0.00
Lexeo Therapeutics (LXEO) United States $0.656B 0.00
Aquestive Therapeutics (AQST) United States $0.647B 0.00
Bioventus (BVS) United States $0.627B 12.83
4D Molecular Therapeutics (FDMT) United States $0.587B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.547B 12.96
Zevra Therapeutics (ZVRA) United States $0.520B 0.00
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.435B 5.96
Altimmune (ALT) United States $0.424B 0.00
Lyell Immunopharma (LYEL) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 21.60
Galectin Therapeutics (GALT) United States $0.357B 0.00
USANA Health Sciences (USNA) United States $0.354B 9.88
Aldeyra Therapeutics (ALDX) United States $0.302B 0.00
Pyxis Oncology (PYXS) United States $0.279B 0.00
Larimar Therapeutics (LRMR) United States $0.272B 0.00
Avalo Therapeutics (AVTX) United States $0.267B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.244B 0.00
OmniAb (OABI) United States $0.219B 0.00
AleAnna (ANNA) United States $0.217B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Protara Therapeutics (TARA) United States $0.203B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.151B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.142B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Relmada Therapeutics (RLMD) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.124B 0.00
Inhibikase Therapeutics (IKT) United States $0.119B 0.00
Unicycive Therapeutics (UNCY) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Gain Therapeutics (GANX) United States $0.108B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Champions Oncology (CSBR) United States $0.095B 34.50
Prelude Therapeutics (PRLD) United States $0.095B 0.00
Karyopharm Therapeutics (KPTI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.088B 0.00
Vivani Medical (VANI) United States $0.086B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.072B 0.00
Plus Therapeutics (PSTV) United States $0.072B 0.00
Nutriband (NTRB) United States $0.068B 0.00
Lite Strategy (LITS) United States $0.068B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.061B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Wellgistics Health (WGRX) United States $0.049B 0.00
Talphera (TLPH) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 26.12
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.013B 0.02
Mangoceuticals (MGRX) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.22
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00